fbpx
May 1, 2025

Clinical Trials

1 min read

Published on: July 12, 2017 at 12:00PM Condition:   Neuroendocrine CarcinomasInterventions:   Drug: Oxaliplatin-based chemotherapy;   Drug: Alkylating-based chemotherapySponsor:   Hospices Civils de LyonNot yet recruiting - verified...

%d bloggers like this: